Find out more about the co-development agreement between Xbrane and STADA for a ranibizumab biosimilar, and about a novel biomarker test for establishing lung cancer risk in smokers in this week’s bioanalytical news round-up.
Browsing: Collaborations and mergers
BioAgilytix (NC, USA) have announced their partnership with Sword Bio (IL, USA), to expand their bioanalytical services to include Sword Bio’s detection platform for immunoassays.
Read time: 2 mins
Read more about the latest advances in proteomics this week in our themed weekly news round-up, including news regarding a new clinical market license for a predictive diagnostic test for diabetic kidney disease, and a new device for in vivo real-time proteomics in surgical oncology.
Read time: 1 min
Citoxlab Group (Évreux, France) has announced it will acquire Solvo Biotechnology (Budaörs, Hungary) securing its position as a leader among the top five non-clinical CROs.
Charles River (MA, USA) to expand global position with the procurement of global CRO, MPI Research (MI, USA).
Alturas Analytics and Metrendalytics announce new technology to streamline operations in the modern scientific laboratory
Alturas Analytics (ID, USA) and Metrendalytics (NJ, USA) have announced a new information system combining common laboratory software programs into a single system.
Charles River Laboratories (MA, USA) have acquired Brains On-Line (CA,USA), a CRO specializing in therapeutics for the treatment of CNS diseases.
LGC (Teddington, UK) have announced the combination of their Biosearch oligonucleotide reagent group with the newly acquired LINK technology, in the hope of enhancing oligonucleotide capabilities.
Thermo Fisher Scientific announces collaboration with SRI International to advance small molecule research
Thermo Fisher Scientific announces collaboration with SRI International, incorporating SRI International’s BioCyc database collection to the Thermo Scientific Compound Discoverer 2.1 software platform.
PerkinElmer aims to expand their reach into the autoimmune and allergy diagnostic market through a $1.3 billion acquisition of EUROIMMUN.